A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514
Clinical trial NCT05264038 · COMPLETED
Trial details
- NCT number
- NCT05264038
- Sponsor
- Oncocross Australia Pty Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-03
- Primary completion
- 2022-09-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.